[Controlled clinical study of the effect of combined administration of ethacrynic acid and spironolactone in ascitic liver cirrhosis].
D001201:Ascites / Q000188:drug therapy*; D004341:Drug Evaluation; D004357:Drug Synergism; D004976:Ethacrynic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D013148:Spironolactone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013148:Spironolactone; D004976:Ethacrynic Acid
Studio clinico controllato sugli effetti della somministrazione combinata di acido etacrinico e di spironolattone nella cirrosi epatica in fase ascitica.